Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

ARENSIA Exploratory Medicine - Sofia ( Site 0018), Sofia

Anima ( Site 0013), Alken

ARENSIA Exploratory Medicine-SC ARENSIA Exploratory Medicine SRL with Monza Medical Center ( Site 00, Bucharest

Paddington Testing Company ( Site 0010), Philadelphia

Advanced Medical Research, PC. ( Site 0027), Sandy Springs

Global Health Research Center, Inc. ( Site 0005), Miami Lakes

Miami Dermatology and Laser Research ( Site 0025), Miami

Genesis Clinical Research, LLC ( Site 0004), Tampa

ForCare Clinical Research ( Site 0003), Tampa

Remington Davis Clinical Research ( Site 0021), Columbus

AXIS Clinicals ( Site 0029), Dilworth

Arkansas Research Trials-Clinical Trials ( Site 0002), North Little Rock

North Texas Center for Clinical Research ( Site 0028), Frisco

Complete Dermatology ( Site 0023), Sugar Land

Progressive Clinical Research ( Site 0022), San Antonio

Premier Clinical Research ( Site 0026), Spokane

ARENSIA Exploratory Medicine-Country Emergency Hospital- Arensia,Cluj-Napoca ( Site 0017), Cluj-Napoca

Innovaderm Research Inc. ( Site 0019), Montreal

Hospital Germans Trias i Pujol-CCEE Dermatologia ( Site 0012), Badalona